Akorn (AKRX): Notes From Management Meetings - Jefferies

August 29, 2016 7:40 AM EDT
Get Alerts AKRX Hot Sheet
Price: $18.23 --0%

Rating Summary:
    12 Buy, 7 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 15 | New: 18
Trade AKRX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Jefferies analyst, David Steinberg, reiterated his Buy rating on shares of Akorn (NASDAQ: AKRX) after hosting the company for two days of investor meetings. A focal point was market dynamics for AKRX’s largest product ephedrine ($200M+). This remains a very fluid situation with many factors at play.

Other key topics included AKRX’s 86 ANDA pipeline & M&A. Post these meetings, the analyst expects near term volatility as the ephedrine story plays out but the analyst likes the risk-reward profile at current levels given likely robust new product flow and potential acquisitions.

No change to the price target of $35.00

For an analyst ratings summary and ratings history on Akorn click here. For more ratings news on Akorn click here.

Shares of Akorn closed at $26.86 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Management Comments

Related Entities

Jefferies & Co

Add Your Comment